UPMC Hillman Cancer Center, Magee-Womens Hospital — Pittsburgh, Pennsylvania

UPMC Hillman Cancer Center, Magee-Womens Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UPMC Hillman Cancer Center, Magee-Womens Hospital has participated in 1 clinical trials.

Therapeutic areas: Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53.

Sponsors: Aprea Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Hillman Cancer Center, Magee-Womens Hospital?

UPMC Hillman Cancer Center, Magee-Womens Hospital has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Hillman Cancer Center, Magee-Womens Hospital conducted?

UPMC Hillman Cancer Center, Magee-Womens Hospital has 1 clinical trials on record. Their work covers Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53.

Is UPMC Hillman Cancer Center, Magee-Womens Hospital accredited by Crixeo Health?

UPMC Hillman Cancer Center, Magee-Womens Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Hillman Cancer Center, Magee-Womens Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.